Thymosin Beta 4 ICCC

Thymosin Beta 4 ICCCWhat is Thymosin Beta 4? It is a peptide, specifically designed to help speed up the repair and recovery process in the event of an injury. Promotes blood vessel regeneration Stimulates faster wound healing and minimises scarring Reduces joint inflammation Promotes organ regeneration Improves levels of stamina and greater endurance BIOV8 uses only premium pharmaceutical grade ingredients in all of our products. Please refer to clinical studies and

What is Thymosin Beta 4?

It is a peptide, specifically designed to help speed up the repair and recovery process in the event of an injury.

• Promotes blood vessel regeneration
• Stimulates faster wound healing and minimises scarring
• Reduces joint inflammation
• Promotes organ regeneration
• Improves levels of stamina and greater endurance

BIOV8 uses only premium pharmaceutical grade ingredients in all of our products.

Please refer to clinical studies and trials below.

Click here for more information.

What are the benefits?

• Promotes wound healing
• Promotes muscle building and improved muscular tone
• Speeds up the recovery time for muscle fibers and cells
• Improved flexibility
• Calms muscular spasms
• Accelerates muscle growth, increases muscle tone, endurance, and strength
• Decreases inflammation of joints and improves flexibility
• Regenerates cells in vital organs
• Prevents the formation of adhesions and fibrous bands within muscles, tendons, and tissue

What are the effects?

• Endothelial (blood vessels) cell migration and differentiation
• Angiogenesis (growth of new blood cells from pre-existing vessels) in dermal tissues
• Keratinocyte migration
• Collagen deposition
• Increased exchange of substances between cells
• Encourages tissue repair
• Stretches connective tissue and helps maintain flexibility

How does it work?

Thymosin Beta 4 is different from other repair factors, such as growth factors. It has been shown to promote endothelial and keratinocyte migration. One of its critical mechanisms of action is the up-regulation of the cell-building protein, Actin. Actin is essential for cell structure and mobility, aiding the building of new blood vessel pathways. Thymosin Beta 4 also regulates inflammation related to wound healing. Its molecular structure and low molecular weight enable it to travel efficiently through tissues, targeting injury sites and initiating corrective action.

When stacked with other GHRH and GHRP products, recovery times can be shortened by half. Studies show that Thymosin Beta 4 is the first gene to be upregulated after an injury. It assists in creating new vessels at the injury site to carry blood, nutrients, and healing substances. Additionally, it controls the inflammatory response, preventing excessive cytokine release, which can lead to uncontrolled inflammation.

Thymosin Beta 4 is also being studied for its potential therapeutic benefits in treating conditions like HIV, AIDS, Influenza, Colds, and various infections. Its ability to aid heart recovery after a heart attack has also been explored.

DOSAGE

Inject: 0.2 - 0.3 mL SUBQ injection to the abdomen nightly

Oral: 1 capsule daily

Course Duration: up to 12 weeks

What are the side effects?

Thymosin Beta 4 is very well-tolerated, and there have been no serious side effects reported. It can be used alone or alongside other therapies, making it a versatile peptide.

Common Thymosin Beta 4 stacks

Thymosin Beta 4 is often stacked with BPC-157, which focuses on muscle, bone, and gut repair. These peptides are paired due to the multi-area impact injuries often have on the body. BIOV8 offers a Rapid Repair Bundle that contains both BPC-157 and Thymosin Beta 4.

Research and Clinical Studies

• Thymosin beta 4 up-regulates miR-200a expression and induces differentiation and survival of rat brain progenitor cells. Santra M, Chopp M, Santra S, et al. J Neurochem. 2016 Jan;136(1):118-32.
• Expression of thymosin beta-4 in human periodontal ligament cells and its role in osteoblastic/cementoblastic differentiation. Lee SI, Lee DW, et al. Differentiation. 2015 Jul-Oct;90(1-3):16-26.
• C-terminal variable AGES domain of Thymosin β4: the molecule's primary contribution in support of post-ischemic cardiac function and repair. Hinkel R, Ball HL, et al. J Mol Cell Cardiol. 2015 Oct;87:113-25.
• Novel modulators of hepatosteatosis, inflammation and fibrogenesis. Lakshman MR, Reyes-Gordillo K, et al. Hepatol Int. 2014 Sep;8 Suppl 2:413-20.
• Correction: Thymosin beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. PLOS ONE Staff. PLoS One. 2015 Feb 19;10(2):e0118428.

Note: All injectables come with the required sharps and swabs for the treatment plan. If you're purchasing a vial, we recommend purchasing a sharps box for safe disposal.